Navigation Links
New knowledge about the brain's effective bouncer

Research from the University of Copenhagen is shedding new light on the brain's complicated barrier tissue. The blood-brain barrier is an effective barrier which protects the brain, but which at the same time makes it difficult to treat diseases such as Alzheimer's. In an in vitro blood-brain barrier, researchers can recreate the brain's transport processes for the benefit of the development of new pharmaceuticals for the brain. The new research findings are published in the AAPS Journal.

Ninety-five per cent of all tested pharmacological agents for treating brain disorders fail, because they cannot cross the blood-brain barrier. It is therefore important to find a possible method for transporting drugs past the brain's efficient outpost and fervent protector.

Researchers at the Department of Pharmacy at the University of Copenhagen have recreated the complex blood-brain barrier in a laboratory model, which is based on cells from animals. In a new study, the researchers have studied the obstreperous bouncer proteins in the barrier tissue. The proteins protect the brain, but also prevent the treatment of brain diseases:

"The blood-brain barrier is chemically tight because the cells contain transporter proteins which make sure that substances entering the cells are thrown straight back out into the bloodstream again. We have shown that the barrier which we have created in the laboratory contains the same bouncer proteins and that they behave in the same way as in a 'real' brain. This is important, because the model can be used to test drive the difficult way into the brain. Complex phenomena which we have so far only been able to study in live animals can now be investigated in simple laboratory experiments using cultivated cells," says postdoc Hans Christian Cederberg Helms from the Department of Pharmacy.

The research team has shown that the transporter proteins P-glycoprotein, breast cancer resistance protein and multidrug resistance-associated protein 1 are active in the artificially created barrier tissue. The proteins pump pharmacological agents from the 'brain side' to the 'blood side' in the same way as in the human blood-brain barrier.

Collaboration finds a way

The new findings have resulted from collaboration with industrial scientists from the pharmaceutical company H. Lundbeck A/S.

"It is important to the treatment of brain diseases such as Alzheimer's that we find a way of circumventing the brain's effective defence. The university and industry must work together to overcome the fundamental challenges inherent in developing pharmaceuticals for the future," says Lassina Badolo, Principal Scientist with H. Lundbeck A/S and an expert on the absorption of medicines in the body.

Associate Professor Birger Brodin adds:

"We have shown that the models have the same bouncer proteins as the ones found in the intact barrier. We are now in the process of studying the proteins in the blood-brain barrier that accept pharmacological agents instead of throwing them out. If we can combine a beneficial substance which the brain needs with a so-called 'absorber protein', we will in the long term be able to smuggle pharmacological agents across the blood-brain barrier."


Contact: Birger Brodin
University of Copenhagen The Faculty of Health and Medical Sciences

Related biology news :

1. Researchers uncover new knowledge about our intestines
2. Architecture of signaling proteins enhances knowledge of key receptors
3. Canadian physicians lack knowledge and confidence about breastfeeding
4. New atom-scale knowledge on the function of biological photosensors
5. Thousands of new particles in workplaces despite large knowledge gap
6. New knowledge about serious muscle disease
7. Knowledge about incontinence and pelvic organ prolapse lower among women of color
8. Reproductive biologists move in vitro fertilization knowledge forward
9. New framework to deliver biodiversity knowledge
10. New knowledge about permafrost improving climate models
11. Ag, big data, and traditional knowledge headline the Ecological Society of Americas 2013 Meeting
Post Your Comments:
(Date:6/27/2016)... June 27, 2016 Research and Markets has ... 2016-2020" report to their offering. ... America to grow at a CAGR of 12.28% during ... based on an in-depth market analysis with inputs from industry experts. ... the coming years. The report also includes a discussion of the ...
(Date:6/22/2016)... American College of Medical Genetics and Genomics was once again ... of the fastest-growing trade shows during the Fastest 50 Awards ... Las Vegas . Winners are ... of the following categories: net square feet of paid exhibit ... 2015 ACMG Annual Meeting was ranked 23 out of 50 ...
(Date:6/22/2016)... 2016   Acuant , the leading ... has partnered with RightCrowd ® to ... Management, Self-Service Kiosks and Continuous Workforce Assurance. ... functional enhancements to existing physical access control ... with an automated ID verification and authentication ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... Lemonade Stand Foundation (ALSF), a leading national childhood cancer ... bioinformatics lab, using ,big data, to advance the pace ... Liz Scott , co-executive director of ALSF and Alex,s ... Washington, D.C. , hosted by Vice President ... pediatric cancer research and awareness. The ...
(Date:6/27/2016)... , June 27, 2016  Global demand for ... percent through 2020 to $7.2 billion.  This market ... beverages, cleaning products, biofuel production, animal feed, and ... diagnostics, and biocatalysts). Food and beverages will remain ... by increasing consumption of products containing enzymes in ...
(Date:6/27/2016)... ON , June 27, 2016 /PRNewswire/ - BIOREM Inc. ... has been advised by its major shareholders, Clean Technology ... United States based venture capital ... shares of Biorem (on a fully diluted, as converted ... the disposition of their entire equity holdings in Biorem ...
(Date:6/27/2016)... SAN DIEGO , June 27, 2016  Sequenom, ... company committed to enabling healthier lives through the development ... Supreme Court of the United States ... Federal courts that the claims of Sequenom,s U.S. Patent ... the patent eligibility criteria established by the Supreme Court,s ...
Breaking Biology Technology: